Allopurinol and Platelet Function

Introduction to Allopurinol

• Allopurinol significantly interacts with azathioprine and 6-mercaptopurine, requiring dose reductions of 65-75% of these agents when used concomitantly, according to the American Society of Clinical Oncology 1

Drug Interactions and Hematologic Effects

• The American Academy of Otolaryngology-Head and Neck Surgery notes that allopurinol itself is not listed among medications requiring dose adjustment when used with antiplatelet agents 2
• The American College of Chest Physicians states that allopurinol is not included in clinical practice guidelines for antiplatelet therapy as a medication affecting platelet function 3
• Increased vigilance is warranted in patients with renal impairment, as allopurinol is excreted by the kidneys and dose reduction is recommended in renal insufficiency, as suggested by the Journal of Clinical Oncology 1

Monitoring and Precautions

• Regular monitoring of complete blood counts is advisable, especially during the first few months of therapy, although no specific citation is provided for this recommendation
• However, the interaction between allopurinol and other medications, such as azathioprine and 6-mercaptopurine, can lead to myelosuppression, including thrombocytopenia, which warrants careful monitoring 1